Literature DB >> 21813769

IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity.

Karla D Kenyon1, Caroline Cole, Fran Crawford, John W Kappler, Joshua M Thurman, Donna L Bratton, Susan A Boackle, Peter M Henson.   

Abstract

Defective clearance of apoptotic cells has been shown in systemic lupus erythematosus (SLE) and is postulated to enhance autoimmune responses by increasing access to intracellular autoantigens. Until now, research has emphasized inherited rather than acquired impairment of apoptotic cell engulfment in the pathogenesis of SLE. In this study, we confirm previous results that efficient removal of apoptotic cells (efferocytosis) is bolstered in the presence of wild-type mouse serum, through the C3 deposition on the apoptotic cell surface. In contrast, sera from three mouse models of SLE, Mer(KD), MRL(lpr), and New Zealand Black/WF1 did not support and in fact actively inhibited apoptotic cell uptake. IgG autoantibodies were responsible for the inhibition, through the blockade of C3 recognition by macrophages. Consistent with this, IgG removal reversed the inhibitory activity within autoimmune serum, and purified autoimmune IgG blocked both the detection of C3 on apoptotic cells and C3-dependent efferocytosis. Sera from SLE patients demonstrated elevated anti-C3b IgG that blocked detection of C3 on apoptotic cells, activity that was not found in healthy controls or patients with rheumatoid arthritis, nor in mice prior to the onset of autoimmunity. We propose that the suppression of apoptotic cell disposal by Abs against deposited C3 may contribute to increasing severity and/or exacerbations in SLE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813769      PMCID: PMC3159788          DOI: 10.4049/jimmunol.1003468

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  The final step in programmed cell death: phagocytes carry apoptotic cells to the grave.

Authors:  Aimee M deCathelineau; Peter M Henson
Journal:  Essays Biochem       Date:  2003       Impact factor: 8.000

2.  Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.

Authors:  Irith Baumann; Wasilis Kolowos; Reinhard E Voll; Bernhard Manger; Udo Gaipl; Winfried L Neuhuber; Thomas Kirchner; Joachim R Kalden; Martin Herrmann
Journal:  Arthritis Rheum       Date:  2002-01

3.  Activation of the alternative pathway of complement by apoptotic Jurkat cells.

Authors:  H Matsui; S Tsuji; H Nishimura; S Nagasawa
Journal:  FEBS Lett       Date:  1994-09-12       Impact factor: 4.124

4.  Immunoconglutinins of different immunoglobulin classes demonstrated by the antiglobulin reaction.

Authors:  P M Henson
Journal:  Immunology       Date:  1968-05       Impact factor: 7.397

5.  Augmentation of NZB autoimmune phenotypes by the Sle1c murine lupus susceptibility interval.

Authors:  Brendan M Giles; Svetlana N Tchepeleva; Julie J Kachinski; Katherine Ruff; Byron P Croker; Laurence Morel; Susan A Boackle
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

Review 6.  Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients.

Authors:  Yaniv Sherer; Alexander Gorstein; Marvin J Fritzler; Yehuda Shoenfeld
Journal:  Semin Arthritis Rheum       Date:  2004-10       Impact factor: 5.532

7.  Phagocytosis and clearance of apoptotic cells is mediated by MER.

Authors:  R S Scott; E J McMahon; S M Pop; E A Reap; R Caricchio; P L Cohen; H S Earp; G K Matsushima
Journal:  Nature       Date:  2001-05-10       Impact factor: 49.962

8.  Detection and characterization of immunoconglutinins in patients with systemic lupus erythematosus (SLE): serial analysis in relation to disease course.

Authors:  B Nilsson; K N Ekdahl; A Sjöholm; U R Nilsson; G Sturfelt
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

9.  Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells.

Authors:  P R Hoffmann; A M deCathelineau; C A Ogden; Y Leverrier; D L Bratton; D L Daleke; A J Ridley; V A Fadok; P M Henson
Journal:  J Cell Biol       Date:  2001-11-12       Impact factor: 10.539

10.  Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase.

Authors:  Philip L Cohen; Roberto Caricchio; Valsamma Abraham; Todd D Camenisch; J Charles Jennette; Robert A S Roubey; H Shelton Earp; Glenn Matsushima; Elizabeth A Reap
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  18 in total

1.  Do autoantibodies to C3 exacerbate autoimmunity in SLE?

Authors:  David Killock
Journal:  Nat Rev Rheumatol       Date:  2011-09-06       Impact factor: 20.543

Review 2.  Complement in Lupus Nephritis: New Perspectives.

Authors:  Lihua Bao; Patrick N Cunningham; Richard J Quigg
Journal:  Kidney Dis (Basel)       Date:  2015-06-30

Review 3.  Apoptotic cell clearance: basic biology and therapeutic potential.

Authors:  Ivan K H Poon; Christopher D Lucas; Adriano G Rossi; Kodi S Ravichandran
Journal:  Nat Rev Immunol       Date:  2014-01-31       Impact factor: 53.106

4.  Early assessment of subclinical myocardial injury in systemic lupus erythematosus by two-dimensional longitudinal layer speckle tracking imaging.

Authors:  Xiaofang Zhong; Lixin Chen; Guijuan Peng; Yuanyuan Sheng; Xiaohua Liu; Yingqi Zheng; Yuxiang Huang; Jinfeng Xu; Yingying Liu
Journal:  Quant Imaging Med Surg       Date:  2022-05

5.  SCARF1-Induced Efferocytosis Plays an Immunomodulatory Role in Humans, and Autoantibodies Targeting SCARF1 Are Produced in Patients with Systemic Lupus Erythematosus.

Authors:  April M Jorge; Taotao Lao; Rachel Kim; Samantha Licciardi; Joseph El Khoury; Andrew D Luster; Terry K Means; Zaida G Ramirez-Ortiz
Journal:  J Immunol       Date:  2022-01-26       Impact factor: 5.422

Review 6.  Prix Fixe: Efferocytosis as a Four-Course Meal.

Authors:  Jennifer Martinez
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

7.  Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.

Authors:  Daniel J Birmingham; Joshua E Bitter; Ezinne G Ndukwe; Sarah Dials; Terese R Gullo; Sara Conroy; Haikady N Nagaraja; Brad H Rovin; Lee A Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

8.  Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis.

Authors:  Vasil V Vasilev; Remi Noe; Marie-Agnes Dragon-Durey; Sophie Chauvet; Valentin J Lazarov; Boriana P Deliyska; Veronique Fremeaux-Bacchi; Jordan D Dimitrov; Lubka T Roumenina
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

9.  Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity.

Authors:  Lucrezia Colonna; Graham C Parry; Sandip Panicker; Keith B Elkon
Journal:  Clin Immunol       Date:  2016-01-06       Impact factor: 3.969

Review 10.  How macrophages deal with death.

Authors:  Greg Lemke
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.